Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

3SBio (83B) Stock Price & Analysis

1 Followers

83B Stock Chart & Stats

€1.71€0.05(3.19%)
At close: 5:30 PM GMT+1
€1.6€1.7€1.8€1.9Aug 10Aug 19Oct 8Oct 12Nov 2
Day’s Range
EUR 1.70 - EUR 1.71
52-Week Range
EUR 1.47 - EUR 3.78
Previous Close
EUR 1.66
Volume
N/A
Average Volume (3M)
172
Market Cap
EUR 4.41B
Enterprise Value
EUR 28.64B
Total Cash (Recent Filing)
EUR 17.59B
Total Debt (Recent Filing)
EUR 1.39B
Price to Earnings (P/E)
4.0
Beta
0.54
Next Earnings
Mar 30, 2027 (Est.)
EPS Estimate
0.06
Next Dividend Ex-Date
N/A
Dividend Yield
1.57%

Bulls Say, Bears Say

Bulls Say

Revenue And Profitability

The sharp 2025 acceleration shows strong commercial momentum across 3SBio’s biopharmaceutical portfolio, while very high margins indicate substantial earnings leverage. If maintained, this combination can fund research, commercialization, and expansion while strengthening the company’s competitive position.

Conservative Balance Sheet

materially lower leverage improves financial resilience and gives 3SBio more flexibility to invest in products, therapies, and market expansion. The simultaneous growth in equity and assets supports a stronger platform for scaling operations without relying heavily on additional borrowing.

Strong Cash Generation

Free cash flow closely tracking net income suggests that the 2025 earnings improvement was supported by cash generation rather than accounting profit alone. Strong internal funding can support research and development, commercialization, debt management, and shareholder returns over coming quarters.

Bears Say

Earnings Durability

The abrupt step-change in 2025 performance has not yet established a consistent multi-year pattern. Earlier variability in growth and margins makes future earnings harder to forecast and creates a risk that the unusually strong 2025 profitability will moderate as comparisons normalize.

Uneven Cash Conversion

Earlier periods of weaker cash conversion show that reported earnings have not always translated into cash at the same rate. If that pattern returns, internally generated funds available for research, product expansion, debt reduction, and other capital priorities could be less dependable.

Inconsistent Returns

The wide variation in return on equity indicates that capital efficiency has not been consistently strong across the business cycle. Although 2025 was impressive, sustaining that level depends on maintaining recent profitability and asset productivity rather than relying on a single exceptional year.

3SBio News

83B FAQ

What was 3SBio’s price range in the past 12 months?
3SBio lowest stock price was €1.47 and its highest was €3.78 in the past 12 months.
What is 3SBio’s market cap?
3SBio’s market cap is €4.41B.
When is 3SBio’s upcoming earnings report date?
3SBio’s next earnings report is estimated for Mar 30, 2027 (not yet confirmed), which is in 140 days.
How were 3SBio’s earnings last quarter?
3SBio released its earnings results on Aug 20, 2026. The company reported €0.058 earnings per share for the quarter, missing the consensus estimate of €0.084 by -€0.026.
Is 3SBio overvalued?
According to Wall Street analysts 3SBio’s price is currently Undervalued.
Does 3SBio pay dividends?
3SBio does not currently pay dividends.
What is 3SBio’s EPS estimate?
3SBio’s EPS estimate is 0.06.
How many shares outstanding does 3SBio have?
3SBio has 2,538,981,000 shares outstanding.
What happened to 3SBio’s price movement after its last earnings report?
3SBio reported an EPS of €0.058 in its last earnings report, missing expectations of €0.084. Following the earnings report the stock price went down -6.541%.
Which hedge fund is a major shareholder of 3SBio?
Currently, no hedge funds are holding shares in DE:83B
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology